MPTP parkinsonism.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000328:Adult; D000818:Animals; D006801:Humans; D008297:Male; D051379:Mice; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D011725:Pyridines / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D012453:Saimiri; D012642:Selegiline / Q000494:pharmacology; D019966:Substance-Related Disorders
D011725:Pyridines; D012642:Selegiline; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine